Literature DB >> 9649205

Endogenous glucocorticoids modulate neutrophil migration and synovial P-selectin but not neutrophil phagocytic or oxidative function in experimental arthritis.

M Leech1, P Hutchinson, S R Holdsworth, E F Morand.   

Abstract

Pharmacologic glucocorticoids are powerful inhibitors of the inflammatory response at many levels, including leucocyte trafficking and function. The adhesion molecule P-selectin is a key participant in polymorphonuclear neutrophil (PMN) migration to sites of inflammation. The extent to which endogenous glucocorticoids influence PMN migration and activation is not clear. We used the glucocorticoid receptor antagonist RU486 to examine the effect of endogenous glucocorticoid blockade on PMN migration and function in carrageenan monoarthritis in the rat. Arthritis was induced by intraarticular injection of carrageenan and disease severity measured by PMN count in synovial lavage fluid. Decalcified frozen sections of injected joints were analysed for expression of P-selectin by immunohistochemistry. Adrenal glucocorticoid action was blocked in vivo with RU486 20 mg/kg. PMN phagocytosis and reactive oxygen species synthesis were measured by flow cytometry. Carrageenan injection was associated with severe arthritis (synovial lavage PMN 5.9 +/- 0.7 x 10(6), P < 0.01 versus control) which was dose-dependent. P-selectin was not detected in normal joints but was abundant in joints injected with 500 microg carrageenan. RU486 resulted in exacerbation of carrageenan arthritis (9.7 +/- 0.8 x 10(6), P < 0.05). RU486 also altered the threshold for disease induction, in that most RU486-treated animals were susceptible to arthritis at a dose of carrageenan (2.5 microg) which did not induce arthritis in most control-treated animals (P < 0.05), denoting an altered threshold for arthritis induction. RU486 treatment was associated with increased synovial P-selectin expression. Activation status as measured by PMN phagocytic and oxidative function were not influenced by endogenous glucocorticoid blockade. These findings suggest that endogenous glucocorticoids selectively influence PMN migration to inflamed joints via P-selectin expression, but have no effect on PMN activation status.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9649205      PMCID: PMC1905001          DOI: 10.1046/j.1365-2249.1998.00601.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  40 in total

1.  Dose effects of LPS on neutrophils in a whole blood flow cytometric assay of phagocytosis and oxidative burst.

Authors:  R H Böhmer; L S Trinkle; J L Staneck
Journal:  Cytometry       Date:  1992

Review 2.  Poly's lament: the neglected role of the polymorphonuclear neutrophil in the afferent limb of the immune response.

Authors:  A R Lloyd; J J Oppenheim
Journal:  Immunol Today       Date:  1992-05

3.  A fast and easy method to determine the production of reactive oxygen intermediates by human and murine phagocytes using dihydrorhodamine 123.

Authors:  A Emmendörffer; M Hecht; M L Lohmann-Matthes; J Roesler
Journal:  J Immunol Methods       Date:  1990-08-07       Impact factor: 2.303

4.  Inflammatory mediator-induced hypothalamic-pituitary-adrenal axis activation is defective in streptococcal cell wall arthritis-susceptible Lewis rats.

Authors:  E M Sternberg; J M Hill; G P Chrousos; T Kamilaris; S J Listwak; P W Gold; R L Wilder
Journal:  Proc Natl Acad Sci U S A       Date:  1989-04       Impact factor: 11.205

5.  Monocyte-endothelial adhesion in chronic rheumatoid arthritis. In situ detection of selectin and integrin-dependent interactions.

Authors:  J S Grober; B L Bowen; H Ebling; B Athey; C B Thompson; D A Fox; L M Stoolman
Journal:  J Clin Invest       Date:  1993-06       Impact factor: 14.808

6.  Killing of immature CD4+ CD8+ thymocytes in vivo by anti-CD3 or 5'-(N-ethyl)-carboxamide adenosine is blocked by glucocorticoid receptor antagonist RU-486.

Authors:  M Jondal; S Okret; D McConkey
Journal:  Eur J Immunol       Date:  1993-06       Impact factor: 5.532

7.  The effect of in vitro and in vivo dexamethasone on human neutrophil function.

Authors:  D A Lomas; M Ip; A Chamba; R A Stockley
Journal:  Agents Actions       Date:  1991-07

8.  A mechanism for the antiinflammatory effects of corticosteroids: the glucocorticoid receptor regulates leukocyte adhesion to endothelial cells and expression of endothelial-leukocyte adhesion molecule 1 and intercellular adhesion molecule 1.

Authors:  B N Cronstein; S C Kimmel; R I Levin; F Martiniuk; G Weissmann
Journal:  Proc Natl Acad Sci U S A       Date:  1992-11-01       Impact factor: 11.205

9.  Interleukin 1 beta mediates stress-induced immunosuppression via corticotropin-releasing factor.

Authors:  A Saperstein; H Brand; T Audhya; D Nabriski; B Hutchinson; S Rosenzweig; C S Hollander
Journal:  Endocrinology       Date:  1992-01       Impact factor: 4.736

10.  Defective hypothalamic response to immune and inflammatory stimuli in patients with rheumatoid arthritis.

Authors:  I C Chikanza; P Petrou; G Kingsley; G Chrousos; G S Panayi
Journal:  Arthritis Rheum       Date:  1992-11
View more
  9 in total

1.  Glucocorticoid receptor-mediated suppression of activator protein-1 activation and matrix metalloproteinase expression after spinal cord injury.

Authors:  J Xu; G M Kim; S H Ahmed; J Xu; P Yan; X M Xu; C Y Hsu
Journal:  J Neurosci       Date:  2001-01-01       Impact factor: 6.167

2.  Macrophage migration inhibitory factor inhibits the antiinflammatory effects of glucocorticoids via glucocorticoid-induced leucine zipper.

Authors:  Huapeng Fan; Wenping Kao; Yuan H Yang; Ran Gu; James Harris; Günter Fingerle-Rowson; Richard Bucala; Devi Ngo; Elaine Beaulieu; Eric F Morand
Journal:  Arthritis Rheumatol       Date:  2014-08       Impact factor: 10.995

3.  Endogenous glucocorticoids modulate neutrophil function in a murine model of haemolytic uraemic syndrome.

Authors:  S A Gómez; G C Fernández; G Camerano; G Dran; F A Rosa; P Barrionuevo; M A Isturiz; M S Palermo
Journal:  Clin Exp Immunol       Date:  2005-01       Impact factor: 4.330

4.  Independent roles of macrophage migration inhibitory factor and endogenous, but not exogenous glucocorticoids in regulating leukocyte trafficking.

Authors:  Julia L Gregory; Pam Hall; Michelle Leech; Eric F Morand; Michael J Hickey
Journal:  Microcirculation       Date:  2009-11       Impact factor: 2.628

5.  Endogenous glucocorticoids attenuate Shiga toxin-2-induced toxicity in a mouse model of haemolytic uraemic syndrome.

Authors:  S A Gómez; G C Fernández; S Vanzulli; G Dran; C Rubel; T Berki; M A Isturiz; M S Palermo
Journal:  Clin Exp Immunol       Date:  2003-02       Impact factor: 4.330

6.  Maraviroc, a chemokine receptor-5 antagonist, fails to demonstrate efficacy in the treatment of patients with rheumatoid arthritis in a randomized, double-blind placebo-controlled trial.

Authors:  Dona L Fleishaker; Juan A Garcia Meijide; Andriy Petrov; Michael David Kohen; Xin Wang; Sujatha Menon; Thomas C Stock; Charles A Mebus; James M Goodrich; Howard B Mayer; Bernhardt G Zeiher
Journal:  Arthritis Res Ther       Date:  2012-01-17       Impact factor: 5.156

7.  Role of crotoxin, a phospholipase A2 isolated from Crotalus durissus terrificus snake venom, on inflammatory and immune reactions.

Authors:  D F Cardoso; M Lopes-Ferreira; E L Faquim-Mauro; M S Macedo; S H Farsky
Journal:  Mediators Inflamm       Date:  2001-06       Impact factor: 4.711

8.  Prokaryotic RNA Associated to Bacterial Viability Induces Polymorphonuclear Neutrophil Activation.

Authors:  Nahuel Rodriguez-Rodrigues; Luis A Castillo; Verónica I Landoni; Daiana Martire-Greco; M Ayelén Milillo; Paula Barrionuevo; Gabriela C Fernández
Journal:  Front Cell Infect Microbiol       Date:  2017-07-06       Impact factor: 5.293

9.  Klebsiella pneumoniae ST258 Negatively Regulates the Oxidative Burst in Human Neutrophils.

Authors:  Luis A Castillo; Federico Birnberg-Weiss; Nahuel Rodriguez-Rodrigues; Daiana Martire-Greco; Fabiana Bigi; Veronica I Landoni; Sonia A Gomez; Gabriela C Fernandez
Journal:  Front Immunol       Date:  2019-04-26       Impact factor: 7.561

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.